Phylogica is one of few companies in the biologics sector that combines a proprietary library of
peptides enriched for drug-like properties, with a powerful screening technology; together
these yield high quality drug leads. We consider it is companies with validated libraries of
potential drugs, rather than technology platform companies, which merely provide enabling
technologies, that are likely to realise the most value from partnering or collaborating with
pharmaceutical companies, even at the preclinical stage.
- Forums
- ASX - By Stock
- PYC
- Ann: Trading Halt
Ann: Trading Halt , page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $536.5M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.5¢ | $79.90K | 665.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 215009 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 507819 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 215009 | 0.120 |
14 | 256451 | 0.115 |
14 | 590932 | 0.110 |
17 | 1046749 | 0.105 |
23 | 2405533 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 507819 | 7 |
0.130 | 448338 | 7 |
0.135 | 104632 | 1 |
0.140 | 721230 | 7 |
0.145 | 298572 | 9 |
Last trade - 11.20am 04/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |